Saluda Medical Appoints New CEO Barry Regan to Transform Neuromodulation Landscape
Saluda Medical Welcomes Barry Regan as New CEO
Saluda Medical, Inc., known for its innovative approach in neuromodulation technology, has taken a significant step in enhancing its leadership team by appointing Barry Regan as the President and Chief Executive Officer, effective July 14, 2025. This decision aligns with the company’s ambitions to scale its operations and expand its influence within the medical device industry, specifically in treatments for chronic neurological conditions.
Mr. Regan comes to Saluda with over 30 years of substantial experience in the medical device and pharmaceutical sectors. His previous role was as Executive Vice President of Global Operations at Dexcom, where he played a pivotal role in overseeing capital investment strategies and manufacturing processes for continuous glucose monitoring products. His wealth of knowledge also includes a tenure as Senior Vice President of Global Operations at Wright Medical, where he demonstrated a consistent ability to drive growth and enhance operational efficiency.
The appointment of Regan is part of a broader strategy by Saluda Medical to fortify its executive team, following the recent hiring of Mike Mathias as Chief Commercial Officer and Jim Erickson as Chief Financial Officer. Doug Godshall, Chairman of the Board of Directors, expressed excitement about Regan’s加入, remarking on the critical juncture that the company is currently at.